Status:
RECRUITING
Quality of Life Improvement During Chemotherapy
Lead Sponsor:
Christian Schwegler
Conditions:
Breast Cancer Female
Chemotherapy Effect
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study is a randomized controlled trial, taking place at the University Hospital Basel (CH). It aims at the alleviation of breast cancer patients' life quality during chemotherapy. The interventi...
Detailed Description
Background: Breast cancer patients who undergo chemotherapy are likely to experience lower life quality, side effects like nausea and vomiting and symptoms of anxiety or depression. At the same time ...
Eligibility Criteria
Inclusion
- Minimum Age 18 years
- Female
- Primary breast cancer
- Receiving neo-adjuvant or adjuvant chemotherapy
Exclusion
- Verbal or cognitive deficits that are not compatible with outpatient psychotherapy
- Not consenting patients and vulnerable persons
- Psychological disorders that prevent patients from participating in the study (e.g. psychotic disorder)
- acute suicidality
Key Trial Info
Start Date :
July 31 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2026
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT04694885
Start Date
July 31 2021
End Date
December 30 2026
Last Update
July 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Basel
Basel, Canton of Basel-City, Switzerland, 4031